AlanPestronkMD
Neurology • Saint Louis, MONeuromuscular Medicine
Professor of Neurology & Pathology and Immunology, Washington University St Louis
Dr. Pestronk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 314-362-1408Fax+1 314-747-8427
Summary
- Dr. Alan Pestronk is a neurologist in Saint Louis, MO. He Is Professor of Neurology and Immunology and Pathology at Washington University School of Medicine and is affiliated with Barnes-Jewish Hospital, and St. Louis Children's Hospital. He received his medical degree from Johns Hopkins University School of Medicine. He specializes in neuromuscular medicine, inflammatory myopathies, muscle and nerve pathology, and muscular dystrophy. Website: https://neuromuscular.wustl.edu/
Education & Training
Johns Hopkins UniversityResidency, Neurology, 1971 - 1974
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1970 - 1971- Johns Hopkins University School of MedicineClass of 1970
Certifications & Licensure
IL State Medical License 2020 - 2026
MO State Medical License 1989 - 2026
MD State Medical License 1971 - 1989- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2005-2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
- Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2005 Dec 01
- A Phase 2 Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy Start of enrollment: 2012 May 01
- Therapy in Amyotrophic Lateral Sclerosis (TAME) Start of enrollment: 2018 Nov 07
Publications & Presentations
PubMed
- Seeding-competent TDP-43 persists in human patient and mouse muscle.Eileen M Lynch, Sara Pittman, Jil Daw, Chiseko Ikenaga, Sheng Chen
Science Translational Medicine. 2024-11-27 - Ophthalmoparesis as an unusual manifestation of anti-3‑hydroxy-3-methyl-glutaryl-coenzyme A reductase antibody-associated myopathies.Brendan Putko, Alan Pestronk, Gregory P Van Stavern, Cecile L Phan, Grayson Beecher
Neuromuscular Disorders. 2024-09-01 - 3 citationsSafety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial.Rabi Tawil, Kathryn R Wagner, Johanna I Hamel, Doris G Leung, Jeffrey M Statland
The Lancet. Neurology. 2024-05-01
Journal Articles
- CANOMAD and Other Chronic Ataxic Neuropathies with Disialosyl Antibodies (CANDA)R Brian Sommerville, Craig M Zaidman, Glenn Lopate, Alan Pestronk, Conrad C Weihl, Robert C Bucelli, Journal of Neurology
Press Mentions
Newfound Autoimmune Syndrome Causes Muscle Pain, WeaknessApril 29th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
